US Allergic Conjunctivitis Companies

Alcon launches Pataday Once Daily Relief Extra Strength: This extended-release formulation of olopatadine hydrochloride offers 24-hour allergy symptom relief with a single daily dose.

Bausch & Lomb introduces Alaway Preservative Free Antihistamine Eye Drops: This first-of-its-kind over-the-counter option caters to patients with sensitive eyes who require preservative-free solutions.

Eyevance Pharmaceuticals receives FDA approval for ZERVIATE (cetirizine ophthalmic solution) 0.24%: This marks the first new prescription-only medication for allergic conjunctivitis approved in the US in over a decade.

Aciex Therapeutics partners with Alcon for commercialization of its novel ALK-specific immunotherapy for allergic conjunctivitis: This collaboration aims to bring a potentially transformative treatment option to patients faster.

Regen Therapeutics reports early promise for its RGN259 treatment in a Phase 2 study for allergic conjunctivitis: This gene therapy approach offers a potential long-term solution for managing allergy symptoms.

• Bausch & Lomb Incorporated


• Aldeyra Therapeutics


• Vanda Pharmaceuticals


• NoveomeBiotherapeutics


• Allakos, Inc.


• Regeneron Pharmaceuticals


• Marinomed Biotech AG


• Eleusis Holdings Ltd


• IACTA Pharmaceuticals


• W. Pharmaceutical